178 related articles for article (PubMed ID: 24036049)
1. Dabigatran-induced esophagitis.
Ootani A; Hayashi Y; Miyagi Y
Clin Gastroenterol Hepatol; 2014 Jul; 12(7):e55-6. PubMed ID: 24036049
[No Abstract] [Full Text] [Related]
2. Extensive dabigatran-induced exfoliative esophagitis harboring squamous cell carcinoma.
Zimmer V; Casper M; Lammert F
Endoscopy; 2014; 46 Suppl 1 UCTN():E273-4. PubMed ID: 24906097
[No Abstract] [Full Text] [Related]
3. Dabigatran-induced acute hepatitis.
Rochwerg B; Xenodemetropoulos T; Crowther M; Spyropoulos A
Clin Appl Thromb Hemost; 2012 Sep; 18(5):549-50. PubMed ID: 22962308
[No Abstract] [Full Text] [Related]
4. Dabigatran-associated spontaneous acute cervical epidural hematoma.
Bamps S; Decramer T; Vandenbussche N; Verhamme P; Thijs V; Van Loon J; Theys T
World Neurosurg; 2015 Feb; 83(2):257-8. PubMed ID: 25463422
[No Abstract] [Full Text] [Related]
5. [Exfoliative esophagitis while taking dabigatran].
Scheppach W; Meesmann M
Dtsch Med Wochenschr; 2015 Apr; 140(7):515-8. PubMed ID: 25826037
[TBL] [Abstract][Full Text] [Related]
6. Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran.
Getta B; Muller N; Motum P; Hsu D; Zebeljan D; Rosenfeld D
Br J Haematol; 2015 May; 169(4):603-4. PubMed ID: 25425051
[No Abstract] [Full Text] [Related]
7. Is there really misuse and abuse of dabigatran?
Eikelboom JW; Hankey GJ
Med J Aust; 2013 Apr; 198(7):358-9. PubMed ID: 23581946
[No Abstract] [Full Text] [Related]
8. Thrombosis on a mechanical mitral valve anticoagulated with dabigatran.
Coulter S; Campos K
J Thromb Thrombolysis; 2014; 37(2):84-6. PubMed ID: 23813022
[No Abstract] [Full Text] [Related]
9. Exfoliative esophagitis and esophageal ulcer induced by dabigatran.
Okada M; Okada K
Endoscopy; 2012; 44 Suppl 2 UCTN():E23-4. PubMed ID: 22396259
[No Abstract] [Full Text] [Related]
10. Dabigatran, bleeding, and the regulators.
Moore TJ; Cohen MR; Mattison DR
BMJ; 2014 Jul; 349():g4517. PubMed ID: 25056265
[No Abstract] [Full Text] [Related]
11. Dabigatran: how the drug company withheld important analyses.
Cohen D
BMJ; 2014 Jul; 349():g4670. PubMed ID: 25055829
[No Abstract] [Full Text] [Related]
12. The trouble with dabigatran.
Charlton B; Redberg R
BMJ; 2014 Jul; 349():g4681. PubMed ID: 25055830
[No Abstract] [Full Text] [Related]
13. Dabigatran "non-inferior" to warfarin, but only just.
BMJ; 2013 Feb; 346():f1219. PubMed ID: 23447339
[No Abstract] [Full Text] [Related]
14. Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhage.
Aron JL; Gosselin R; Moll S; Arkin CF; Mantha S
J Thromb Thrombolysis; 2014; 37(2):76-9. PubMed ID: 23519385
[No Abstract] [Full Text] [Related]
15. [Extensive thromboembolism after cardioversion in a patient treated with dabigatran].
Buch TN; Holm J; Munck LK
Ugeskr Laeger; 2013 Feb; 175(6):333-4. PubMed ID: 23402235
[TBL] [Abstract][Full Text] [Related]
16. Concerns over data in key dabigatran trial.
Cohen D
BMJ; 2014 Jul; 349():g4747. PubMed ID: 25055831
[No Abstract] [Full Text] [Related]
17. Gastrointestinal bleeding under dabigatran.
Stöllberger C; Lindner K; Finsterer J
J Postgrad Med; 2014; 60(2):192-3. PubMed ID: 24823522
[TBL] [Abstract][Full Text] [Related]
18. Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.
Matute MC; Guillán M; García-Caldentey J; Buisan J; Aparicio M; Masjuan J; Alonso de Leciñana M
Thromb Haemost; 2011 Jul; 106(1):178-9. PubMed ID: 21505718
[No Abstract] [Full Text] [Related]
19. Wandering pneumonia caused by dabigatran.
Kono M; Hirota K; Yokoe A; Koumura C; Sakai T; Tojima H
Intern Med; 2014; 53(16):1825-7. PubMed ID: 25130119
[TBL] [Abstract][Full Text] [Related]
20. Uncontrollable haemorrhage following dabigatran prophylaxis.
Sandhu PS; Wilson C; Dalton E; Bogdanov A
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23761516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]